First Author

Author reply to editorials regarding the oral androgen pathway medications IQVIA paper

In this work, we use the IQVIA data science cloud to understand how use of oral androgen pathway directed medications changed during COVID-19

Author reply to editorials regarding the antigrade UGN-101 initial experiences paper

Here, we describe our technique for instillation of UGN-101 via nephrostomy along with early outcomes from our first eight patients treated using this method.

Here, we looked at optimal antimicrobial prophylaxis selection for transurethral procedures throughout the United States using a survey of antibiograms by state. This was the cover article for Jan 2022 UROLOGY.

We explore antimicrobial susceptibility of common urological organisms throughout the United States using a survey of antibiograms.

We wrote a reply discussing the use of oral ketorolac. FDA labelling is for such use only as continuation therapy after parenteral administration. We argue that there is no reason for this.

Patients who undergo radical cystectomy (RC) are at elevated risk of venous thromboembolism and associated morbidity and mortality. Guidelines recommend extended thromboprophylaxis (ETP), typically with heparins, but adherence is low. Outside …

Background: Renal cell carcinoma (RCC) recurrence can present in nearly any location. Rarely, recurrence is within the venous system. Previous reports of such recurrent tumor thrombectomy have all used an open approach.